BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19010329)

  • 1. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
    Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
    Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
    Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
    J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
    Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
    Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
    Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
    Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer.
    Zecevic M; Amos CI; Gu X; Campos IM; Jones JS; Lynch PM; Rodriguez-Bigas MA; Frazier ML
    J Natl Cancer Inst; 2006 Jan; 98(2):139-43. PubMed ID: 16418517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNP association study in PMS2-associated Lynch syndrome.
    Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
    Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.
    Middeldorp A; Jagmohan-Changur SC; van der Klift HM; van Puijenbroek M; Houwing-Duistermaat JJ; Webb E; Houlston R; Tops C; Vasen HF; Devilee P; Morreau H; van Wezel T; Wijnen J
    Genes Chromosomes Cancer; 2010 Jun; 49(6):539-48. PubMed ID: 20222047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
    Middeldorp A; Jagmohan-Changur S; van Eijk R; Tops C; Devilee P; Vasen HF; Hes FJ; Houlston R; Tomlinson I; Houwing-Duistermaat JJ; Wijnen JT; Morreau H; van Wezel T
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3062-7. PubMed ID: 19843678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
    Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
    Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
    Vasen HF; van Ballegooijen M; Buskens E; Kleibeuker JK; Taal BG; Griffioen G; Nagengast FM; Menko FH; Meera Khan P
    Cancer; 1998 May; 82(9):1632-7. PubMed ID: 9576281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new variant database for mismatch repair genes associated with Lynch syndrome.
    Woods MO; Williams P; Careen A; Edwards L; Bartlett S; McLaughlin JR; Younghusband HB
    Hum Mutat; 2007 Jul; 28(7):669-73. PubMed ID: 17347989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.
    Xiong F; Wu C; Bi X; Yu D; Huang L; Xu J; Zhang T; Zhai K; Chang J; Tan W; Cai J; Lin D
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1855-61. PubMed ID: 20530476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.